LAWSUITS NEWS & LEGAL INFORMATION
FDA Monitoring Fibromyalgia Drug Savella (Milnacipran HC) for Suicidal Ideation
Washington, DC: Due to reports on its Adverse Event Reporting System (AERS) of potential suicidal ideation, the Food and Drug Administration (FDA) has placed the antidepressant Milnacipran HCI
(Savella) on AERS watchlist.
Savella is a selective serotonin and norepinephrine reuptake inhibitor (SNRI), similar to some drugs used for the treatment of depression and other psychiatric disorders. Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders.
Savella is mostly prescribed for fibromyalgia, a condition that may cause ongoing pain, muscle stiffness and tenderness, tiredness, and difficulty falling asleep. According to the Mayo Clinic, fibromyalgia affects women more than men and there is no known cause. There is also no cure for fibromyalgia at present. Savella fibromyalgia treatment is possible option for patients who may suffer from the condition.
The FDA is continuing to evaluate this issue and any potential association with Milnacipran HCI (Savella) to determine the need for any regulatory action.
Last updated on
Savella is a selective serotonin and norepinephrine reuptake inhibitor (SNRI), similar to some drugs used for the treatment of depression and other psychiatric disorders. Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders.
Savella is mostly prescribed for fibromyalgia, a condition that may cause ongoing pain, muscle stiffness and tenderness, tiredness, and difficulty falling asleep. According to the Mayo Clinic, fibromyalgia affects women more than men and there is no known cause. There is also no cure for fibromyalgia at present. Savella fibromyalgia treatment is possible option for patients who may suffer from the condition.
The FDA is continuing to evaluate this issue and any potential association with Milnacipran HCI (Savella) to determine the need for any regulatory action.
Legal Help
If you or a loved one has suffered illness, adverse outcomes or damages in this case, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.Last updated on
READ MORE Drugs/Medical Settlements and Legal News
READ MORE Personal Injury Settlements and Legal News
READ MORE Personal Injury Settlements and Legal News
READER COMMENTS
Kori Fehl
on
I started having side effects that were concerning and I called my doctor at the time and I was told to let the medicine work the side effects will go away.
The side effects did not go away they only intensified. I ended up in the ER and almost died.
My blood pressure was so high I was losing my vision. I was slurring my words and at times I made no sense and my heart palpitations were so fast that had I not gone in I would of had a stroke and died.
It wasn't until after I stopped taking it did I find out about the consumer watch group begging to pull this drug. Its a shame that we as patients have to almost lose our lives in hope's to feel better and yet the drug is still on the market and still endangering lives all for the almighty dollar big pharma gets.
Renee White
on
Rachel
on
Paula Westman
on
diane van orman
on
Maria Anne Rubio
on
Please include me in the class suit.